Efficacy and Safety of Nirmatrelvir/Ritonavir for Treating Omicron Variant of COVID-19
Clinical trial NCT05813600 · COMPLETED
Trial details
- NCT number
- NCT05813600
- Sponsor
- Xiangao Jiang
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2022-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.